Partner Headlines - MDCO

  1. Netflix Profit Above Consensus, Panera Bread Boosts Buyback Plan, ...

    GuruFocus
  2. FDA Advisory Committee Recommends Approval of The Medicines Company's ...

    Benzinga
  3. Blood clot preventer gets nod

    IBD
  4. Earnings Scheduled For February 18, 2015

    Benzinga
  5. Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up

    IBD
  6. Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

    Benzinga
  7. Benzinga's Top Upgrades

    Benzinga
  8. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  9. What Investors Should Expect From Rockwell Medical's Next FDA ...

    Benzinga
  10. Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops ...

    Benzinga
  11. Morning Market Losers

    Benzinga
  12. Tuesday's After-Hours Movers

    Benzinga
  13. The Medicines Company Surges Amid Credit Suisse Upgrade

    Benzinga
  14. US Stock Futures Surge Ahead Of Earnings, ADP Data

    Benzinga
  15. The Medicines Company Announces First Patient Enrollment In Phase ...

    Benzinga
  16. Midday Gainers From October 28: Buffalo Wild Wings, Integrated ...

    Benzinga
  17. Morning Market Movers

    Benzinga
  18. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga
  19. BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal ...

    Benzinga
  20. Actavis Expands Antibiotics Presence With Durata Buy

    IBD
  21. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  22. Benzinga's Top Downgrades

    Benzinga
  23. Benzinga's Top Downgrades

    Benzinga
  24. Medicines Co.

    IBD
  25. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire ...

    Benzinga
  26. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD
  27. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; ...

    Benzinga
  28. Medicines Co. Down On Setback In Hospira Patent Case

    IBD
  29. Stocks Hitting 52-Week Lows

    Benzinga
  30. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise ...

    Benzinga
  31. Morning Market Losers

    Benzinga
  32. Benzinga's Top #PreMarket Losers

    Benzinga
  33. Medicines Co. earnings miss

    IBD
  34. Earnings Scheduled For February 19, 2014

    Benzinga
  35. FDA nixes Medicines' drug

    IBD
  36. Mid-Afternoon Market Update: Market Rally Levels Out As Time ...

    Benzinga
  37. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge ...

    Benzinga
  38. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD
  39. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time ...

    Benzinga
  40. Stocks Hitting 52-Week Lows

    Benzinga
  41. UPDATE: Credit Suisse Downgrades The Medicines Company Following ...

    Benzinga
  42. Benzinga's Top #PreMarket Losers

    Benzinga
  43. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting ...

    Benzinga
  44. Mid-Afternoon Market Update: Red Robin Continues to Rally as ...

    Benzinga
  45. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD
  46. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  47. Scanning Leading Stocks For Earnings Growth In 2014

    IBD
  48. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  49. Medicines acquires Rempex

    IBD
  50. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga
  51. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD
  52. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  53. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  54. A Few Stocks Form Bases, But Have Flaws

    IBD
  55. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD
  56. Medicines Co. Mostly Steady After Low-Volume Breakout

    IBD
  57. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  58. Santarus Earnings Should Top 4 Hot Small-Cap Medicals

    IBD
  59. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  60. LinkedIn, Alliance Fiber Lead Q3 Young Gun Earnings

    IBD
  61. Medicines Co. In Late Stages Of Base Formation

    IBD
  62. Medicines Co. sales topped

    IBD
  63. Medicines Co. Reports Mixed Q3 As New Products Await

    IBD
  64. Medicines Co. Sales Beat Estimates As Angiomax Grows

    IBD
  65. UPDATE: Leerink Swann Raises PT on The Medicines Company Following ...

    Benzinga
  66. The Medicines Company, Alnylam Announce Advance Development ...

    Benzinga
  67. The Medicines Company's Publishes Phase III Data from Trials ...

    Benzinga
  68. UPDATE: Bank of America Upgrades Medicines Company on Leverage

    Benzinga
  69. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  70. The Medicines Company Announces Proposed Public Offering of 5.5 ...

    Benzinga
  71. The Medicines Company Announces Positive Phase III Trial Results ...

    Benzinga
  72. Questcor Leads Top 5 Small-Cap, Medical Stocks

    IBD
  73. The Medicines Co., Bristol-Myers Begin Alliance for Recothrom

    Benzinga
  74. Medicines Co. Holding On To Its Recent Big Gains

    IBD
  75. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 7,500 Shares

    GuruFocus
  76. Jefferies Reiterates Buy Rating, $34 PT on Partnership with Alnylam ...

    Benzinga
  77. A Peek Into The Market Before The Trading Starts

    Benzinga
  78. The Medicines Company, Alnylam Announce Global Alliance

    Benzinga
  79. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD
  80. 3D Systems Leads Top 5 Small Caps Despite Stock Slide

    IBD
  81. Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD

    GuruFocus
  82. Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS

    GuruFocus
  83. Medicines (MDCO) President & CFO Glenn Sblendorio sells 125, ...

    GuruFocus
  84. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 2,500 Shares

    GuruFocus
  85. Small Cap Leaders: 3D Systems, IXIA Lead Top 5 Stocks

    IBD
  86. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    IBD
  87. Medicines (MDCO) President & CFO Glenn Sblendorio sells 25,0 ...

    GuruFocus
  88. 5 Key Stock Moves From JPMorgan Health Care Confab

    IBD
  89. UPDATE: Bank of America Merrill Lynch Reiterates Neutral Rating, ...

    Benzinga
  90. Eylea Sales Hurt Regeneron

    IBD
  91. Mid-Afternoon Market Update: Markets Fall Further, Isis Pharma ...

    Benzinga
  92. Medtech Stocks Moving As Conference Makes Waves

    IBD
  93. Medtech Stocks Moving As Conference Makes Waves

    IBD
  94. Mid-Day Market Update: Markets Remain Down, The Medicines Company ...

    Benzinga
  95. The Medicines Co. Offers Results of Phase 3 Trial of Cangrelor ...

    Benzinga
  96. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 5,000 Shares

    GuruFocus
  97. Cadence Pharmaceuticals Terminates Option Agreement to Acquire ...

    Benzinga
  98. Medicines Company to Acquire Incline Therapeutics

    Benzinga
  99. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 13,593 Shares

    GuruFocus
  100. Medicines Company Reports Operating Results (10-Q)

    GuruFocus
Trading Center